Company Profile
Artivion Stock Price, News & Analysis
- Ticker:
- AORT
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
26.57 USD (+1.53%)
Close
Last updated: August 6, 2026
991M USD
Market cap
Why the stock is moving
The latest monitored company update is “Artivion Reports Second Quarter 2026 Financial Results.” The corresponding closing-price reaction is not yet available.
Company overview
Aortic-Disease Technologies
Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease.
Surgical Products
The company supplies aortic stent grafts, surgical adhesives, mechanical heart valves and preserved cardiac and vascular tissues. These products support both open and hybrid procedures.
Endovascular Expansion
Artivion exercised its option to acquire Endospan, developer of the FDA-approved NEXUS Aortic Arch System. The transaction would expand Artivion into endovascular treatment of aortic-arch disease alongside its existing surgical portfolio.
Future catalysts
Artivion's catalysts are On-X valve execution, AMDS progress, and continued aortic-repair adoption. The next update matters if it shows the procedural base is still gaining traction.
Recent news
- 01
Artivion Reports Second Quarter 2026 Financial Results
Source: Artivion
- 02
Artivion to Participate in Upcoming Investor Conferences
Source: Artivion
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Artivion (AORT)?
Artivion (AORT) most recently closed at 26.57 USD, a +1.53% move versus the previous session.
What is the market cap of Artivion (AORT)?
Artivion currently has a market capitalization of 991M USD on BioPharmSignal.
What does Artivion do?
Aortic-Disease Technologies Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease. Surgical Products The company supplies aortic stent grafts, surgical adhesives, mechanical heart valves and...
On which exchange is AORT stock listed?
Artivion (AORT) is associated with NYSE, United States, MedTech.
What is Aortic-Disease?
Aortic-Disease Technologies Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery.
Which conditions is Artivion targeting with Aortic-Disease?
Aortic-Disease Technologies Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease. Surgical Products The company supplies aortic stent grafts, surgical adhesives, mechanical heart valves and...
How does Artivion describe recent progress with Aortic-Disease?
Artivion's catalysts are On-X valve execution, AMDS progress, and continued aortic-repair adoption. The next update matters if it shows the procedural base is still gaining traction.
What is Technologies?
Aortic-Disease Technologies Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery.